Form 8-K - Current report:
SEC Accession No. 0000320017-24-000061
Filing Date
2024-12-03
Accepted
2024-12-03 08:33:26
Documents
13
Period of Report
2024-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K clbs-20241203.htm   iXBRL 8-K 25052
  Complete submission text file 0000320017-24-000061.txt   152933

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20241203.xsd EX-101.SCH 1776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20241203_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20241203_pre.xml EX-101.PRE 13042
15 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20241203_htm.xml XML 2825
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 241521257
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)